Product Information
AMPHETAMINE ER 18.8 MG ODT is a generic product labeled by Neos Therapeutics Brands, LLC, priced at $16.2013 per EA under NDC 62542003030. Its NADAC has been published 31 times since Jan 21, 2026.
FDA first approved this application on Jan 27, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
18.8 mg/1
Manufacturer
Neos Therapeutics Brands, LLCNDC
62542003030
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMPHETAMINEApproval Type
Authorized Generic (NDA)
FDA Application
NDA204326FDA Approved
1/27/2016
TE Code
AB
On Market Since
9/1/2025
Pharmacological Classes
Price Statistics
The NADAC for AMPHETAMINE ER 18.8 MG ODT has been published 31 times since Jan 21, 2026, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $16.2013 per EA |
|---|---|
| All-time high | $16.5172 (Feb 11, 2026) |
| All-time low | $16.2013 (Aug 19, 2026) |
| 52-week high | $16.5172 |
| 52-week low | $16.2013 |
| Median price | $16.3536 |
| Average price | $16.3787 |
| Largest weekly change | -0.8% (Aug 19, 2026) |
| Weeks tracked | 31 |
| Tracking since | Jan 21, 2026 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Amphetamine Extended-Release market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AMPHETAMINE ER 18.8 MG ODT?
The current National Average Drug Acquisition Cost (NADAC) for AMPHETAMINE ER 18.8 MG ODT, manufactured by Neos Therapeutics Brands, LLC, is $16.2013 per EA (NDC 62542003030), effective Aug 19, 2026.
How has the price of AMPHETAMINE ER 18.8 MG ODT changed over time?
Over the history we have for it, the NADAC for AMPHETAMINE ER 18.8 MG ODT has held within roughly two percent of its current level. It has been tracked across 31 weekly CMS publications since Jan 21, 2026.
What are the highest and lowest recorded NADAC prices for AMPHETAMINE ER 18.8 MG ODT?
Since Jan 21, 2026, the NADAC for AMPHETAMINE ER 18.8 MG ODT has ranged from a low of $16.2013 (Aug 19, 2026) to a high of $16.5172 (Feb 11, 2026), with a median of $16.3536 per EA.
Are there cheaper alternatives to AMPHETAMINE ER 18.8 MG ODT?
No other NADAC-published product currently shares the active ingredient and strength of AMPHETAMINE ER 18.8 MG ODT in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures AMPHETAMINE ER 18.8 MG ODT?
AMPHETAMINE ER 18.8 MG ODT (NDC 62542003030) is labeled by Neos Therapeutics Brands, LLC, and CMS classifies it as a generic product.